Floatz logo

Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
VENLOR
Breast Cancer
University of Illinois at ChicagoP4BBB (74)
(+)-Vincristine
Sezary Syndrome
Shanghai Jiao Tong University School of MedicineP4BBB (74)
(+)-Vincristine
Neoplasm
PfizerP4BBB (74)
Vinorelbine Ditartrate
Breast Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd.P4BBB (74)
Vipivotide Tetraxetan
Prostate Cancer
Mayo ClinicP4BBB (74)
Vitamin D
Breast Cancer
University of Illinois at ChicagoP4BBB (74)
Vitamin D
Colorectal Cancer
Tanta UniversityP4BBB (74)
Vitamin D
Obesity Disorder
Agricultural University of AthensP4BBB (74)
XENON
Cystic Fibrosis
University of Kansas Medical CenterP4BBB (74)
Zoledronate
Breast Cancer
Xijing HospitalP4BBB (74)
Zoledronate
Prostate Cancer
Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaP4BBB (74)
Abiraterone
Breast Cancer
M.D. Anderson Cancer CenterP3BBB (74)
Aclarubicin
Acute Myeloid Leukemia
Shanghai Jiao Tong University School of MedicineP3BBB (74)
Adriamycin
Acute Myeloid Leukemia
Janssen Research & Development, LLCP3BBB (74)
Adriamycin
Cancer
Junpeng WangP3BBB (74)
Adriamycin
Colorectal Cancer
Junpeng WangP3BBB (74)
Adriamycin
Fallopian Tube Clear Cell Adenocarcinoma
National Cancer Institute (NCI)P3BBB (74)
Adriamycin
Fallopian Tube Transitional Cell Carcinoma
National Cancer Institute (NCI)P3BBB (74)
Adriamycin
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
National Cancer Institute (NCI)P3BBB (74)
Adriamycin
Large B-Cell Lymphoma
Ruijin HospitalP3BBB (74)
Adriamycin
Metastatic Neoplasm
Eli Lilly and CompanyP3BBB (74)
Adriamycin
Ovarian Cancer
GenmabP3BBB (74)
Adriamycin
Ovarian Clear Cell Adenocarcinoma
National Cancer Institute (NCI)P3BBB (74)
Adriamycin
Ovarian Endometrioid Adenocarcinoma
National Cancer Institute (NCI)P3BBB (74)
Adriamycin
Ovarian Seromucinous Carcinoma
National Cancer Institute (NCI)P3BBB (74)
Showing 1826 to 1850 of 42,289 assets
PreviousPage 74 of 1692Next